Chronic Lymphocytic Leukemia Coverage from Every Angle
ABOUT
SECTIONS
JNCCN Spotlights
Videos
News
Medical Literature
CE Activities
Clinical Trials
For Your Patients
NCCN RESOURCES
NCCN Guidelines
®
NCCN Compendium
®
NCCN Templates
®
NCCN Guidelines for Patients®
360 HUB
Acute Myeloid Leukemia
Bladder Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Immunotherapy
Kidney Cancer
Multiple Myeloma
Non-Melanoma Skin Cancers
Non-Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Thyroid Cancer
JNCCN
Editor:
Jennifer R. Brown, MD, PhD
Advertisement
Advertisement
Resources For Your Patients
NCCN COVID-19 Resources Page
ASH: COVID-19 Resources for Managing Blood Cancers
ASCO: COVID-19 Medical Resources
Cancer.gov
Patient Power
UpToDate
Leukemia & Lymphoma Society
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
NCCN Guidelines for Patients for CLL
CLL Society
NCCN Guidelines for Patients
Know What Your Doctors Know: Chronic Lymphocytic Leukemia
JNCCN Spotlights
?
Acalabrutinib
Venetoclax
View More >
Advertisement
Resources
For your Patients
Patient Power
CLL Society
Cancer.gov
NCCN Guidelines for Patients
Copyright ©
2021
National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.
Bots not welcome here